Clinical Trial Update: A Multicenter, Active and Placebo-controlled Study of Enteric Coated Sevelamer in Patients With Mild to Moderate Hypercholesteremia [Phase 2]

View source ↗

Summary

A Phase 2 multicenter trial evaluating enteric-coated sevelamer in patients with mild to moderate hypercholesterolemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypercholesterolemia

Drugs mentioned

• Sevelamer (Renagel/Renvela) (sevelamer)

Snippet

Sponsor: Genzyme, a Sanofi Company | Conditions: Hypercholesterolemia | Phase 2 | Status: COMPLETED